Tildrakizumab

ATC L04AC17 · 10 markets · 18 records

Tildrakizumab 10 markets · 18 records Forms

AU 4 records · 3 strengths

  • 100 mg/1 mLinjectionILUMYA also in GB
  • 100 mg/mLinjectionILUMYA tildrakizumab (rch) 100 mg/1 mL solution for injection pre-filled syringe also in SG unknown

Records without a stated strength · 1 ILUMYA

ES 3 records · 2 strengths

GB 2 records · 2 strengths

CA 2 records · 1 strengths

US 1 records · 1 strengths

SG 1 records · 1 strengths

  • 100 mg/mLinjectionILUMYA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 100MG/ML also in AU

MX 1 records · 1 strengths

    Records without a stated strength · 1 ILUMYA

    TW 1 records · 1 strengths

    HK 1 records · 1 strengths

      Records without a stated strength · 1 Ilumetri 100 mg solution for injection in pre-filled syringe

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 Ilumetri

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.